Former President Donald Trump called Kentucky Derby-winning horse Medina Spirit a "junky" after a positive drug test.
Medina Spirit tested positive for betamethasone, an anti-inflammatory drug, trainer Bob Baffert announced Sunday morning.
"So now even our Kentucky Derby winner, Medina Spirit, is a junky. This is emblematic of what is happening to our Country. The whole world is laughing at us as we go to hell on our Borders, our fake Presidential Election, and everywhere else!" Trump said in a statement Sunday.
Trump's claims about the "fake" election have been repeatedly debunked.
Baffert said a post-race test following Medina Spirit’s win in the May 1 Kentucky Derby at Churchill Downs revealed 21 picograms of betamethasone.
According to Kentucky Horse Racing Commission regulations, a second positive test — called a “split sample” — is required before a horse can be disqualified.
More:Here's what we know following Kentucky Derby winner Medina Spirit's positive drug test
Churchill Downs has suspended Baffert from entering horses at the track after Sunday’s announcement.
“It is our understanding that Kentucky Derby winner Medina Spirit’s post-race blood sample indicated a violation of the Commonwealth of Kentucky’s equine medication protocols,” Churchill Downs said Sunday in a news release. “The connections of Medina Spirit have the right to request a test of a split sample, and we understand they intend to do so."
“To be clear, if the findings are upheld, Medina Spirit’s results in the Kentucky Derby will be invalidated and Mandaloun will be declared the winner.”
Churchill Downs said it “will await the conclusion of the Kentucky Horse Racing Commission’s investigation before taking further steps” regarding Baffert’s suspension.
More:Can Medina Spirit still race in the Preakness? What positive drug test means for next race
Medina Spirit’s failed test for betamethasone was the fifth known drug-positive in Baffert’s barn in a span of 12 months and at least the 31st of his Hall of Fame career, said Courier Journal columnist Tim Sullivan.
Source link
